{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:41:54Z","timestamp":1781653314212,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,5]]},"DOI":"10.7759\/cureus.106453","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T08:35:40Z","timestamp":1775378140000},"source":"Crossref","is-referenced-by-count":1,"title":["Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review of Efficacy and Safety"],"prefix":"10.7759","author":[{"given":"Hamide","family":"Busmail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasika","family":"Weerakoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethel T","family":"Mandefro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Vidya","family":"Sundara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravanthi","family":"Avula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Inflammatory bowel disease","author":"McDowell C","year":"2023","unstructured":"McDowell C, Farooq U, Haseeb M. Inflammatory bowel disease. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30077-2","article-title":"Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China","volume":"1","author":"Kaplan GG","year":"2016","unstructured":"Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol. 2016, 1:307-16. 10.1016\/S2468-1253(16)30077-2","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: causation or correlation?","volume":"14","author":"Ni J","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation?. Nat Rev Gastroenterol Hepatol. 2017, 14:573-84. 10.1038\/nrgastro.2017.88","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043817","article-title":"Inflammatory bowel diseases and gut microbiota","volume":"24","author":"Haneishi Y","year":"2023","unstructured":"Haneishi Y, Furuya Y, Hasegawa M, Picarelli A, Rossi M, Miyamoto J. Inflammatory bowel diseases and gut microbiota. Int J Mol Sci. 2023, 24:3817. 10.3390\/ijms24043817","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.11.003","article-title":"The microbiome and inflammatory bowel disease","volume":"145","author":"Glassner KL","year":"2020","unstructured":"Glassner KL, Abraham BP, Quigley EM. The microbiome and inflammatory bowel disease. J Allergy Clin Immunol. 2020, 145:16-27.","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2020.5016","article-title":"Dysbiosis of gut microbiota in inflammatory bowel disease: current therapies and potential for microbiota-modulating therapeutic approaches","volume":"21","author":"Alshehri D","year":"2021","unstructured":"Alshehri D, Saadah O, Mosli M, Edris S, Alhindi R, Bahieldin A. Dysbiosis of gut microbiota in inflammatory bowel disease: current therapies and potential for microbiota-modulating therapeutic approaches. Bosn J Basic Med Sci. 2021, 21:270-83. 10.17305\/bjbms.2020.5016","journal-title":"Bosn J Basic Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1603758","article-title":"Cutting edge: probiotics and fecal microbiota transplantation in immunomodulation","volume":"2019","author":"Zeng W","year":"2019","unstructured":"Zeng W, Shen J, Bo T, et al.. Cutting edge: probiotics and fecal microbiota transplantation in immunomodulation. J Immunol Res. 2019, 2019:1603758. 10.1155\/2019\/1603758","journal-title":"J Immunol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413197","article-title":"Advances in fecal microbiota transplantation for gut dysbiosis-related diseases","volume":"12","author":"Hou S","year":"2025","unstructured":"Hou S, Yu J, Li Y, Zhao D, Zhang Z. Advances in fecal microbiota transplantation for gut dysbiosis-related diseases. Adv Sci. 2025, 12:2413197. 10.1002\/advs.202413197","journal-title":"Adv Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.05.004","article-title":"The progression of microbiome therapeutics for the management of gastrointestinal diseases and beyond","volume":"167","author":"Allegretti JR","year":"2024","unstructured":"Allegretti JR, Khanna S, Mullish BH, Feuerstadt P. The progression of microbiome therapeutics for the management of gastrointestinal diseases and beyond. Gastroenterology. 2024, 167:885-902. 10.1053\/j.gastro.2024.05.004","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2024.12.002","article-title":"Optimizing therapeutic potential of fecal transplant in inflammatory bowel disease","volume":"54","author":"Magier SJ","year":"2025","unstructured":"Magier SJ, Morley TS, Kelly CR. Optimizing therapeutic potential of fecal transplant in inflammatory bowel disease. Gastroenterol Clin North Am. 2025, 54:277-93. 10.1016\/j.gtc.2024.12.002","journal-title":"Gastroenterol Clin North Am"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2287073","article-title":"Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review","volume":"15","author":"Meade S","year":"2023","unstructured":"Meade S, Liu Chen Kiow J, Massaro C, Kaur G, Squirell E, Bressler B, Lunken G. Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review. Gut Microbes. 2023, 15:2287073. 10.1080\/19490976.2023.2287073","journal-title":"Gut Microbes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158451","article-title":"Healing from within: how gut microbiota predicts IBD treatment success - a systematic review","volume":"25","author":"Alexandrescu L","year":"2024","unstructured":"Alexandrescu L, Nicoara AD, Tofolean DE, et al.. Healing from within: how gut microbiota predicts IBD treatment success - a systematic review. Int J Mol Sci. 2024, 25:8451. 10.3390\/ijms25158451","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic AD","year":"2014","unstructured":"Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014, 146:1489-99. 10.1053\/j.gastro.2014.02.009","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i23.3317","article-title":"Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?","volume":"27","author":"Nishida A","year":"2021","unstructured":"Nishida A, Nishino K, Sakai K, Owaki Y, Noda Y, Imaeda H. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?. World J Gastroenterol. 2021, 27:3317-26. 10.3748\/wjg.v27.i23.3317","journal-title":"World J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.05.008","article-title":"Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease","volume":"226","author":"Basson AR","year":"2020","unstructured":"Basson AR, Zhou Y, Seo B, Rodriguez-Palacios A, Cominelli F. Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease. Transl Res. 2020, 226:1-11. 10.1016\/j.trsl.2020.05.008","journal-title":"Transl Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01856-9","article-title":"Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study","volume":"21","author":"Crothers JW","year":"2021","unstructured":"Crothers JW, Chu ND, Nguyen LT, et al.. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. BMC Gastroenterol. 2021, 21:281. 10.1186\/s12876-021-01856-9","journal-title":"BMC Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2020.08.009","article-title":"The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease","volume":"55","author":"Haifer C","year":"2020","unstructured":"Haifer C, Leong RW, Paramsothy S. The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease. Curr Opin Pharmacol. 2020, 55:8-16. 10.1016\/j.coph.2020.08.009","journal-title":"Curr Opin Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012774.pub3","article-title":"Fecal transplantation for treatment of inflammatory bowel disease","volume":"4","author":"Imdad A","year":"2023","unstructured":"Imdad A, Pandit NG, Zaman M, et al.. Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2023, 4:CD012774. 10.1002\/14651858.CD012774.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/crocol\/otaa067","article-title":"Fecal microbiota transplantation for ulcerative colitis: an evolving therapy","volume":"2","author":"Sood A","year":"2020","unstructured":"Sood A, Singh A, Midha V, Mahajan R, Kao D, Rubin DT, Bernstein CN. Fecal microbiota transplantation for ulcerative colitis: an evolving therapy. Crohns Colitis 360. 2020, 2:otaa067. 10.1093\/crocol\/otaa067","journal-title":"Crohns Colitis 360"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.sjg_131_22","article-title":"Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: a review","volume":"29","author":"Mahmoudi H","year":"2023","unstructured":"Mahmoudi H, Hossainpour H. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: a review. Saudi J Gastroenterol. 2023, 29:3-11. 10.4103\/sjg.sjg_131_22","journal-title":"Saudi J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i17.2666","article-title":"Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: a randomized controlled trial","volume":"29","author":"Lahtinen P","year":"2023","unstructured":"Lahtinen P, Jalanka J, Mattila E, Tillonen J, Bergman P, Satokari R, Arkkila P. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: a randomized controlled trial. World J Gastroenterol. 2023, 29:2666-78. 10.3748\/wjg.v29.i17.2666","journal-title":"World J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae043","article-title":"Faecal microbiota transplantation engraftment after budesonide or placebo in patients with active ulcerative colitis using pre-selected donors: a randomized pilot study","volume":"18","author":"van Lingen E","year":"2024","unstructured":"van Lingen E, Nooij S, Terveer EM, et al.. Faecal microbiota transplantation engraftment after budesonide or placebo in patients with active ulcerative colitis using pre-selected donors: a randomized pilot study. J Crohns Colitis. 2024, 18:1381-93. 10.1093\/ecco-jcc\/jjae043","journal-title":"J Crohns Colitis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000224","article-title":"Fecal microbiota transplantation for ulcerative colitis: the optimum timing and gut microbiota as predictors for long-term clinical outcomes","volume":"11","author":"Li Q","year":"2020","unstructured":"Li Q, Ding X, Liu K, et al.. Fecal microbiota transplantation for ulcerative colitis: the optimum timing and gut microbiota as predictors for long-term clinical outcomes. Clin Transl Gastroenterol. 2020, 11:e00224. 10.14309\/ctg.0000000000000224","journal-title":"Clin Transl Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16795","article-title":"Gut microbiome-targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta-analysis","volume":"40","author":"Zhang T","year":"2025","unstructured":"Zhang T, Li X, Li J, Sun F, Duan L. Gut microbiome-targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta-analysis. J Gastroenterol Hepatol. 2025, 40:78-88. 10.1111\/jgh.16795","journal-title":"J Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15598","article-title":"Fecal microbiota transplantation therapy in Crohn's disease: systematic review","volume":"36","author":"Fehily SR","year":"2021","unstructured":"Fehily SR, Basnayake C, Wright EK, Kamm MA. Fecal microbiota transplantation therapy in Crohn's disease: systematic review. J Gastroenterol Hepatol. 2021, 36:2672-86. 10.1111\/jgh.15598","journal-title":"J Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003196","article-title":"Preliminary results from a multicenter, randomized trial using fecal microbiota transplantation to induce remission in patients with mild-to-moderate Crohn\u2019s disease","volume":"120","author":"Kao D","year":"2024","unstructured":"Kao D, Wong K, Jijon H, et al.. Preliminary results from a multicenter, randomized trial using fecal microbiota transplantation to induce remission in patients with mild-to-moderate Crohn\u2019s disease. Am J Gastroenterol. 2024, 120:1334-44. 10.14309\/ajg.0000000000003196","journal-title":"Am J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12091755","article-title":"The role of fecal microbiota transplantation in IBD","volume":"12","author":"Fanizzi F","year":"2024","unstructured":"Fanizzi F, D'Amico F, Zanotelli Bombassaro I, et al.. The role of fecal microbiota transplantation in IBD. Microorganisms. 2024, 12:1755. 10.3390\/microorganisms12091755","journal-title":"Microorganisms"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-0792-5","article-title":"Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study","volume":"8","author":"Sokol H","year":"2020","unstructured":"Sokol H, Landman C, Seksik P, et al.. Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study. Microbiome. 2020, 8:12. 10.1186\/s40168-020-0792-5","journal-title":"Microbiome"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161174","article-title":"Systematic review: adverse events of fecal microbiota transplantation","volume":"11","author":"Wang S","year":"2016","unstructured":"Wang S, Xu M, Wang W, et al.. Systematic review: adverse events of fecal microbiota transplantation. PLoS One. 2016, 11:e0161174. 10.1371\/journal.pone.0161174","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238910","article-title":"Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"15","author":"Caldeira LF","year":"2020","unstructured":"Caldeira LF, Borba HH, Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis. PLoS One. 2020, 15:e0238910. 10.1371\/journal.pone.0238910","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi P","year":"2015","unstructured":"Moayyedi P, Surette MG, Kim PT, et al.. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015, 149:102-9.e6. 10.1053\/j.gastro.2015.04.001","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy S","year":"2017","unstructured":"Paramsothy S, Kamm MA, Kaakoush NO, et al.. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017, 389:1218-28. 10.1016\/S0140-6736(17)30182-4","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404451-fecal-microbiota-transplantation-in-inflammatory-bowel-disease-a-systematic-review-of-efficacy-and-safety","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T08:35:41Z","timestamp":1775378141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404451-fecal-microbiota-transplantation-in-inflammatory-bowel-disease-a-systematic-review-of-efficacy-and-safety"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.106453","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,5]]}}}